You have 9 free searches left this month | for more free features.

FLT3 Wild Type (WT)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

Recruiting
  • Stage IV Melanoma
  • Stage III Melanoma
  • Jette, Brussels, Belgium
    Universitair Ziekenhuis Brussel
Sep 29, 2021

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Metastatic Colorectal Cancer. Real-World Data Analysis.

Completed
  • Metastatic Colorectal Cancer
    • Istanbul, Turkey
      Istanbul Medeniyet University Hospital
    Oct 25, 2021

    Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

    Not yet recruiting
    • Recurrent Glioblastoma, IDH-Wildtype
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    May 13, 2023

    Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Biospecimen Collection
    • +5 more
    • Buffalo, New York
    • +1 more
    Jan 27, 2023

    Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

    Recruiting
    • Endometrial Cancer
    • Miami Beach, Florida
    • +6 more
    Jan 31, 2023

    Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional Trial in Changhua (Chinese medicine WT)

    Recruiting
    • Ataxia, Spinocerebellar
    • +2 more
    • Chinese medicine WT
    • Changhua, Taiwan
      Changhua Christian Hospital
    Oct 22, 2021

    Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

    Completed
    • Multiple Myeloma
    • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
    • Standard of care
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 22, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 5, 2022

    Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)

    Recruiting
    • Colo-rectal Cancer
    • Experimental: mXELOX plus cetuximab
    • Active Comparator: FOLFOX plus cetuximab
    • Beijing, China
      Cancer Hospital & Institute, Chinese Academy of Medical Sciences
    Sep 29, 2021

    Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

    Recruiting
    • Metastatic Colorectal Cancer
    • Ann Arbor, Michigan
    • +10 more
    Dec 2, 2022

    Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Santiago De Compostela, A Coruña, Spain
    • +44 more
    Jan 20, 2022

    Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Coppito, L'Aquila, Italy
    • +3 more
    Sep 10, 2021

    Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Anaheim, California
    • +47 more
    Mar 28, 2022

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +8 more
    Apr 5, 2022

    Colorectal Cancer Trial in United States (Cetuximab, Neratinib)

    Withdrawn
    • Colorectal Cancer
    • Gainesville, Florida
    • +11 more
    Oct 26, 2021

    Rectal Cancer Trial in Spain (Panitumumab, 5Fluorouracil, Oxaliplatin)

    Completed
    • Rectal Cancer
    • Elche, Alicante, Spain
    • +10 more
    Mar 16, 2022

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

    Completed
    • Advanced Solid and Hematological TP53wt Tumors
    • Boston, Massachusetts
    • +14 more
    May 20, 2021

    NSCLC Trial in Worldwide (INC280 (capmatinib))

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • INC280 (capmatinib)
    • Long Beach, California
    • +95 more
    Dec 29, 2022

    Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

    Recruiting
    • Polyneuropathy
    • Amyloidosis
    • ECG + echocardiography
    • Answering questionnaires
    • Jette, Belgium Capital City, Belgium
      UZ Brussel
    Jul 14, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Pelareorep
    • +3 more
    • New Brunswick, New Jersey
    • +1 more
    Sep 26, 2022